Chaow Charoenkijkajorn
Sourced from institutional research profiles (UAMS TRI or ARA).
Assistant Professor
Also affiliated: University of Iowa (2022); Houston Methodist (2022–2025); The University of Texas MD Anderson Cancer Center (2022–2023); Vanderbilt University (2022); University of Iowa Hospitals and Clinics (2022–2023); Stanford Medicine (2023–2025); Weill Cornell Medicine (2022–2023); Weill Cornell Medical Center (2022); The University of Texas Medical Branch at Galveston (2022–2023); Stanford University (2023–2026)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Chaow Charoenkijkajorn's research focuses on ophthalmology, with a particular emphasis on optic nerve diseases. Recent publications investigate posterior ischemic optic neuropathy in patients with a history of COVID-19 and nonarteritic anterior ischemic optic neuropathy, as well as the risk of giant cell arteritis in patients with undifferentiated noninfectious uveitis. Other work examines uveomeningeal syndrome presenting with optic disc edema, the evaluation of verteporfin as an antifibrotic agent for glaucoma filtration surgery, and rare intraosseous cavernous hemangioma of the orbit. Charoenkijkajorn also studies audible blink in carotid-cavernous fistula and rhabdomyolysis precipitated by acetazolamide for idiopathic intracranial hypertension. Key collaborators include Murat Gökden, Daisy Alapat, Neriman Gökden, and Sena Zengin, all from the University of Arkansas for Medical Sciences.
Metrics
- h-index: 4
- Publications: 50
- Citations: 52
Positions
-
Assistant Professor publications 2025–2026University of Arkansas for Medical Sciences Institution web page
Selected Publications
-
Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports (2026)
-
Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis (2025)
Collaboration Network
Top Collaborators
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
- Illuminating Blurry Vision: Visualization of Corneal Protein Deposition With Immunofluorescence in Two Illustrative Case Reports
Similar Researchers
Based on overlapping research topics